Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan
media
posted on 2021-07-15, 14:06 authored by Adis Rapid Journals on behalf of:, Haruyuki Hongo, Takako Nagao, Kyoko Nakamura, Tomomi Kitaichi, Yuko Maeno, Teruhisa Tokunaga, Akiko Fukuda, Ichiro KogaArticle full text
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
